Novartis Provides Drug Candidate Compounds to TB Alliance
Novartis has signed an exclusive worldwide licensing agreement with the Global Alliance for TB Drug Development (TB Alliance) for compounds
Novartis has signed an exclusive worldwide licensing agreement with the Global Alliance for TB Drug Development (TB Alliance) for compounds
TB Alliance, a not-for-profit with the mission of discovering and developing better, faster and affordable treatments, announced the appointment of
TB Alliance, a not-for-profit organization with the mission of developing better, faster and affordable treatments for tuberculosis (TB), announced the
Researchers at the University of Sheffield, Imperial College London, and TB Alliance have found evidence that a large gap exists
Shorter TB treatment regimens will reduce the out-of-pocket expenses incurred by both patients and their family members, who often act
TB Alliance, a not-for-profit organization dedicated to developing better, faster, and affordable treatments for tuberculosis (TB), announced the appointment of
Based on positive results from earlier clinical studies, TB Alliance is advancing the first-ever drug regimen designed to treat both
TB Alliance, an international non-profit drug development organization that develops better, faster-acting, and affordable tuberculosis (TB) drugs, has announced that
TB Alliance, an international non-profit that develops better, faster-acting, and affordable tuberculosis (TB) drugs, announced today the establishment of an
TB Alliance today announced the launch of its new web portal (www.tballiance.org/children) which seeks to bridge an information gap that